A combined analysis of breast cancer patients in the METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) cohort suggested a lower survival probability in patients with diminished TREX1 expression [77]. This evidence concerns the gene TREX1 and breast carcinoma.